Want to create an interactive transcript for this episode?
Podcast: Relentless Health Value
Episode: EP401: The Most Interesting Questions About the IRA Drug Price Negotiations, With Peter J. Neumann, ScD
Description: Somebody wrote on Twitter the other day that he was gonna give a talk on the use of evidence in drug policy, and Barrett Montgomery replied, "That'll be a short talk then!" So, let's talk about the IRA (Inflation Reduction Act) for a moment, specifically the "CMS can negotiate for drugs for Medicare patients" part of the IRA. There's one topic I don't hear discussed what I would consider maybe often enough. Will these negotiations result in pricing that is evidence based? Will good drugs that companies developed using less taxpayer money for R&D...